<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="activity_corpus\PMC8037164\results\search\plant_compound\results.xml">
  <result pre="reported that some chemical modifications of the OH group of" exact="thymol" post="led to broad-spectrum growth inhibition on all isolates. Preferred"/>
  <result pre="to use natural compounds as templates for the medicinal semi-synthesis." exact="thymol" post="Helicobacter pylori AGS cells semi-synthesis drug resistance dual-action agents,"/>
  <result pre="and anti-inflammatory agent [1]. As well as its regioisomer carvacrol," exact="thymol" post="could exert an inhibitory effect on Gram-positive and Gram-negative"/>
  <result pre="lipidic multilayer structures are strongly suggested [7]. More in detail," exact="thymol" post="derivatives have been proposed as inhibitors of CagA and"/>
  <result pre="in the stomach and duodenum [10]. In the last years," exact="thymol" post="has been the focus of some research studies on"/>
  <result pre="procedure previously employed by our group for the synthesis of" exact="carvacrol" post="derivatives [15]. Thymol (1) was reacted with the proper"/>
  <result pre="treatment of H. pylori-related gastric cancer development. The phenolic terpene" exact="thymol" post="and its 38 semi-synthetic derivatives were firstly assayed against"/>
  <result pre="and F34/497, were the most sensitive to the treatment with" exact="thymol" post="(1) (MIC/MBC of 64 Âµg/mL), slightly better than the"/>
  <result pre="(Et, n-Pr, n-Bu) presented improved MIC values with respect to" exact="thymol" post="against some clinical isolates (MIC/MBC = 16 Âµg/mL). Similar"/>
  <result pre="Âµg/mL). Similar results were obtained for the aliphatic derivatives of" exact="carvacrol" post="in our previous paper [15]. Among the second cluster"/>
  <result pre="to thymol. Finally, the insertion on the OH group of" exact="thymol" post="of a naphthalene ring (37) was detrimental, whereas the"/>
  <result pre="the insertion on the OH group of thymol of a" exact="naphthalene" post="ring (37) was detrimental, whereas the presence of a"/>
  <result pre="effect at 24 h with respect to its positional isomer" exact="carvacrol" post="(IC50 = 300 Â± 6.4 Î¼M). Out of 11"/>
  <result pre="carvacrol (IC50 = 300 Â± 6.4 Î¼M). Out of 11" exact="thymol" post="derivatives, only three (9, 15, 38) presented a dose-dependent"/>
  <result pre="development of such compounds in the clinical settings. Our top-rated" exact="thymol" post="derivatives were devoid of this property. Moreover, their drug-likeness"/>
  <result pre="of Compounds 2â€&quot;7 and 9â€&quot;39 To a stirring solution of" exact="thymol" post="(1, 1.0 equiv.) in dry DMF (10 mL) was"/>
  <result pre="mL). The precipitate was collected by filtration and washed with" exact="n-hexane" post="to give the title compound 8, without further purification"/>
  <result pre="Bovine Serum (FBS) (EuroClone S.p.A., Pero, Italy). Working solutions of" exact="thymol" post="(1) and its derivatives (9, 15, 24â€&quot;26, 30, 34â€&quot;36,"/>
  <result pre="on AGS cells was observed (data not shown). 5-Fluorouracil and" exact="carvacrol" post="(Sigma-Aldrich, Milan, Italy) were used as positive controls. 3.6."/>
  <result pre="(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)) assay (Promega, Madison, WI, USA). The concentration ranges of" exact="thymol" post="and its derivatives for the treatment was extrapolated from"/>
  <result pre="This approach allowed us to demonstrate, as also reported for" exact="carvacrol" post="analogues, that the antibacterial activity of these phenolic terpenes"/>
  <result pre="into selected therapeutic applicationsMolecules202025412510.3390/molecules25184125 2.KachurK.SuntresZ.The antibacterial properties of phenolic isomers," exact="carvacrol" post="and thymolCrit. Rev. Food Sci. Nutr.2020603042305310.1080/10408398.2019.167558531617738 3.MarcheseA.OrhanI.E.DagliaM.BarbieriR.Di LorenzoA.NabaviS.F.GortziO.IzadiM.NabaviS.M.Antibacterial and"/>
  <result pre="with emphasis on its anticancer mechanismsIUBMB Life20197191910.1002/iub.193530308112 12.KangS.H.KimY.S.KimE.K.HwangJ.W.JeongJ.H.DongX.LeeJ.W.MoonS.H.JeonB.T.ParkP.J.Anticancer effect of" exact="thymol" post="on AGS human gastric carcinoma cellsJ. Microbiol. Biotechnol.201526283710.4014/jmb.1506.0607326437948 13.GÃ¼nes-BayirA.KocyigitA.GÃ¼lerE.M.KiziltanH.S.Effects"/>
  <result pre="vitroAltern. Ther. Health Med.201925122129477139 14.GÃ¼nes-BayirA.KocyigitA.GulerE.M.DadakA.In vitro hormetic effect investigation of" exact="thymol" post="on human fibroblast and gastric adenocarcinoma cellsMolecules202025327010.3390/molecules25143270 15.SistoF.CarradoriS.GuglielmiP.TraversiC.B.SpanoM.SobolevA.P.SecciD.Di MarcantonioM.C.HalociE.GrandeR.et"/>
  <result pre="thymol-based compounds 2â€&quot;39. (a) Functionalization of the OH moiety of" exact="thymol" post="(1); (b) ester hydrolysis to provide compound 8. molecules-26-01829-t001_Table"/>
  <result pre="compound 8. molecules-26-01829-t001_Table 1Table 1 MIC and MBC values for" exact="thymol" post="(1, parent compound), its semi-synthetic derivatives (2â€&quot;39), and carvacrol"/>
  <result pre="for thymol (1, parent compound), its semi-synthetic derivatives (2â€&quot;39), and" exact="carvacrol" post="against eight strains of H. pylori. Antibiotic susceptibility according"/>
  <result pre="16/32 39 16/16 32/64 32/64 16/32 16/32 16/32 32/64 16/32" exact="carvacrol" post="64/64 64/64 64/64 64/64 64/64 32/64 64/64 16/32 Antibiotic"/>
  <result pre="of three experiments with quintuplicate determinations. Compound IC50 (Î¼M) a" exact="thymol" post="(1) 200 Â± 6.5 9 100 Â± 5.8 15"/>
 </snippets>
</snippetsTree>
